Dan Malven is a Managing Director of 4490 Ventures, a leading early-stage venture capital firm. Dan’s background is a blend of venture capital investing, startup operational and corporate executive experience. Dan was the founding CEO of Analyte Health, a digital health company, an executive in the consumer health services group of Walgreens, and a co-founder of two software technology companies. Dan has invested in approximately 20 early-stage startups over his career. Four of those investments exited via IPO, with those companies possessing an aggregated current public market capitalization of approximately $10 billion, and several others have exited via acquisition. Dan has a Masters of Business Administration from the Kellogg School of Management at Northwestern University and a Bachelor of Science in Industrial Engineering from Purdue University. Dan is an alumni of the Kauffman Fellows Program and a member of YPO.